Coordinating Pharma Communications & Website Migration for a Breakthrough Oncology Treatment.
While on contract with Brightworks, I project managed the Canadian adaptation and rollout of BeiGene’s Brukinsa® (zanubrutinib) — a BTK inhibitor approved for multiple B-cell malignancies — across both print and digital channels. This work spanned branded promotional assets, patient and HCP support materials, and a full website migration from U.S. to Canadian regulatory and language standards.
Key Responsibilities & Highlights:
- Oversaw the Canadian launch and localization of Brukinsa.ca, migrating web content from the U.S. site while managing internal copywriters, designers, QA, and external web developers.
- Coordinated Health Canada-compliant materials with the Pharmaceutical Advertising Advisory Board (PAAB) and ensured seamless French translation/localization with third-party linguists and print vendors.
- Managed production and delivery of bilingual print and display assets, including:
- Dosing guides & patient support brochures
- Journal advertisements & comparative tools
- Pull-up banners, table-top displays & conference materials
- Full patient support kits for myBeiGene® program integration
- Maintained timelines and budgets while aligning medical, creative, and digital teams under tight regulatory oversight.
